Bivalirudin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72572-035

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 72572-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bivalirudin Civica 01)

Chemical structure of bivalirudin, depicting its molecular composition with peptide bonds, side chains, and various functional groups including amides, carboxyls, and phenyl rings. The structure also indicates a variable component represented by x associated with CF3CO2H.*

FDA Label Image

Carton (Bivalirudin Civica 02)

Box packaging label for Bivalirudin for Injection 250 mg vial, containing 10 single-dose vials for intravenous use. The product is distributed by Civica, Inc. and manufactured by Patheon Italia, S.p.A., Italy. Label indicates it is for single-dose use only and includes storage instructions and dosage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.